期刊文献+

降钙素原联合APACHE Ⅲ在急性重症胆管炎患者预后评估中的意义 被引量:2

Procalcitionin of serum and APACHE Ⅲ can be used to predict prognosis in patients with acute cholangitis of severe type
下载PDF
导出
摘要 目的探讨血清PCT与APACHE Ⅲ评分在急性重症胆管炎患者预后评估中的意义。方法通过对92例急性重症胆管炎患者入院及术后1d、3d、5d检测血清PCT和进行APACHE Ⅲ评分,根据患者预后分为生存组和死亡组,分析PCT与APACHE Ⅲ和预后之间的关系。结果 92例患者生存73例,死亡19例,死亡率20.65%。生存组和死亡组术后3d、5d PCT有差异(P<0.01);APACHE Ⅲ评分在生存组和死亡组中评分值始终有差异(P<0.01)。相关性分析提示PCT在术后3d、5d与预后有相关性(P<0.01),并且在3d时PCT值与预后有最大相关系数0.89;APACHE Ⅲ评分与预后有相关性(P<0.01)。ROC曲线及曲线下面积AUC值提示PCT在3d、5d有评估作用(P<0.01),APACHE Ⅲ有持续评估作用(P<0.01)。结论术后3d、5d PCT与APACHE Ⅲ评分均能够较为准确的评估ACST患者预后,有助于及时预测死亡风险,故监测术后3d、5d PCT在临床上具有指导意义。 Objective To investigate procalcitionin (PCT) of serum and APACHE Ill score in predicting the prognosis of patients with acute cholangitis of severe type (ACST). Methods 92 patients with ACST were detected for serum PCT and APACHE III score before operation and postoperative 1d, 3d, 5d. The patients were divided into survival group and death group. The relationship between PCT, APACHE III score and prognosis were analyzed. Results 73 cases of 92 patients were survived, 19 cases dead, and the mortality rate is 20. 65%. There were significantly differences (P 〈0. 01 ) for 3d, 5d PCT between survival group and death group. APACHE III scores were significantly different ( P 〈 0. 01 ) between the survival group and death group. Correlation analysis showed that PCT in the postoperative 3d, 5d were significantly correlated (P 〈 0. 01 ) with the prognosis in the survival group and death group, and maximum correlation coefficient of 0. 89 was appeared at postoperative 3d. APACHE III scores and the prognosis were significantly correlated (P 〈 0. 01 ) via analyzing the survival group and death group. ROC curves and the area under the curve (AUC) showed that serum PCT in 3d, 5d can be used to assess the prognosis of ACST (P 〈 0. 01 ) and APACHE III scores are always (P 〈 0. 01 ). Conclusion PCT of serum at postoperative 3d, 5d and APACHE III score can be used to predict the prognosis of patients with ACST accurately.
出处 《广州医药》 2014年第3期48-51,共4页 Guangzhou Medical Journal
关键词 降钙素原 APACHE 急性重症胆管炎 Procalcitionin APACHE III Acute eholangitis of severe type
  • 相关文献

参考文献7

  • 1孙胜男,吕菁君,魏捷.脓毒症患者降钙素原浓度与病原学感染证据之间的相关性研究[J].中华急诊医学杂志,2013,22(10):1136-1141. 被引量:42
  • 2张宗新.降钙素原在细菌感染性疾病诊断中的应用探讨[J].检验医学,2006,21(2):117-119. 被引量:59
  • 3郑树国,董家鸿.胆道外科急症危重程度评估及预后判断[J].中国实用外科杂志,2003,23(6):331-332. 被引量:9
  • 4Knaus W,Wagner D,Draper E. APACHE Ⅲ study design:analytic plan for evaluation of severity and outcome in intensive care unit patients.Development of APACHE[J].CRITICAL CARE MEDICINE,1989,(17):181-185.
  • 5Paul E,Bailey M,Van Lint A. Performance of APACHE Ⅲ over time in Australia and New Zealand:a retrospective cohort study[J].Anaesthesia and Intensive Care,2012,(06):980-994.
  • 6Kabbani LS,Escobar GA,Knipp B. APACHE Ⅲ score on ICU admission predicts hospital mortality after open thoracoabdominal and open abdominal aortic aneurysm repair[J].Annals of Vascular Surgery,2010,(08):1060-1067.
  • 7Jeon EJ,Jung JW,Choi JC. The value of procalcitonin and the SAPS Ⅱ and APACHE Ⅲ scores in the differentiation of infectious and non-infectious fever in the ICU:a prospective,cohort study[J].Journal of Korean Medical Science,2010,(11):1633-1637.

二级参考文献18

  • 1侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:869
  • 2Hausfater P, Garric S, Ayed S, et al. Usefulness of procaleitonin as a marker of systemic infection in emergency department patients: aprospective study [J].Clin Infect Dis, 2002, 34 : 895-901.
  • 3Van Leenwen H J, Voorbij HAM. Procalcitonin concentrations in the diagnosis of acute inflammatory reactions[J]. Ned Tijdschr Geneesked, 2002, 146: 55-59.
  • 4Ferriere F. Procalcitonin, a new marker for bacterial infections[J]. Ann Biol Clin, 2000, 58: 49-59.
  • 5Hatherill M, Tibby SM, Sykes K, et al. Diagnostic markers of infection: comparison of procalcitonin with C-reactive protein and leucocyte count [J]. Anh Dischild, 1999, 81 : 417-421.
  • 6王鸿利,顾荣泉,宁嗣宗,等.血液学及血液学检验[M].第2版.北京:人民卫生出版社,1997.35.
  • 7Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care [J]. Crit Cm'e Med, 2001, 29 (7): 1303- 1310.
  • 8Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/ SIS: 2001 SCCM/ ESICM/ ACCP/ A'IS/SIS International Sepsis Definitions Conference [ J]. Crit Care Med, 2003, 31 (4): 1250- 12.56.
  • 9Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosoeomial infections [J]. Am J Iniect Control, 1988, 16 (1) : 128- ldO.
  • 10Soong J, Soni N. Sepsis: recognition and treatment [ J ]. Clin Med, 2012, 12 (3) : 276-280.

共引文献107

同被引文献17

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部